Protocol No.: D3250C00024

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma (DOMINICA)
Principal Investigator
Peppers, Brian
Phase
III
Age Group
Children
Applicable Disease Site
Pediatrics
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Robin Hoffer
Phone: +1 724-972-9170

View on ClinicalTrials.gov